CVE-2026-42040

unknowncovered by 1 sourcefirst seen 2026-07-03

Multiple vulnerabilities have been discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation, and a remote denial of service.

CSIRTS triage

What: Multiple vulnerabilities can allow remote arbitrary code execution, privilege escalation, and remote denial of service.
Who is affected: Users of IBM products.
Urgency: Remediation urgency is unclear but should be prioritized due to potential impacts.
Action: Monitor for updates from IBM regarding these vulnerabilities.

AI-assisted analysis generated from the source advisory — verify against the original.

⚡ Watch CVE-2026-42040

Get an email if CVE-2026-42040 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.

Exploitation outlook

Low exploitation risk0.22% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 12% of all EPSS-scored CVEs.

Advisory coverage (1)

unknownMultiple vulnerabilities in IBM products (July 3, 2026)cert-fr-avis · 2026-07-03

External references

NVD record for CVE-2026-42040

CVE.org record

Embed the live status

— this badge updates automatically when the KEV or exploit status changes. How to embed it →

[![CVE-2026-42040 status](https://www.csirts.com/badge/CVE-2026-42040)](https://www.csirts.com/cve/CVE-2026-42040)